1Wheelock M J, Johnson KR. Cadherins as modulators of cellular phenotype[J]. Annu Rev Cell Dev Biol, 2003, 19(2) : 207.
2Cavallaro U, Christofori G, Multitasking in tumor progression: signaling functions of cell adhesion molecules[ J]. Ann N Y Acad Sci, 2004,10(14) : 58.
3Roylance R, Droufakou S, Gorman P,et al. The role of E -cadherin in low- grade ductal breast tumourigenesis[ J]. J Pathol, 2003,200( 1 ) :53.
4Chen H, Sigrum K, Jon GJ,et al. Alterations of E - cadherin andβcatenin in grastic cancer[ J]. BMC Cancer,2001,1 ( 1 ) : 16.
5Sloan EK,Anderson RL. Genes involved in breast cancer metastasis to bone[J]. Cell Mol Life Sci,2002,59(9) : 1491.
6Debies MT, Welch DR. Genetic basis of human breast cancer metastasis[ J]. J Mammary Gland Biol Neop lasia,2001,6(4) : 441.
7Sugimachi K, Tanaka S, Kameyama T, et al. Transcriptional repressor snail and progression of human hepatocellular carcinoma [ J ]. Clin Cancer Res,2003,9(20) : 2657.
8Hajra MK, David YS, Chen YSD, et al. The SLUG zinc - finger protein represses E -cadherin in breast cancer[ J]. Cancer Res,2002,62(15) :1613.
9Cavallaro U, Christofori G. Cell adhesion and signalling by cadherins and Ig- CAMs in cancer[J]. Nat Rev Cancer, 2004, 4(2) : 118.
10Fuchs M, Hutzler P, Brunner I, et al. Motility enhancement by tumor derived mutant E -cadherin is sensitive to treatment with epidermal growth factor recep tor and phosphatedylin - ositol 3kinase inhibitors[ J]. Exp Cell Res,2002,276 (2) : 129.
